Misonix, Inc. (MSON)
Stock Price:
$14.20 USD
-0.07 (-0.49%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
246.54M |
| Revenue (ttm) |
58.52M |
| Net Income (ttm) |
-11.23M |
| Shares Out |
17.36M |
| EPS (ttm) |
-0.88 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 13, 2020 |
| Last Price |
$14.20 |
| Previous Close |
$14.27 |
| Change ($) |
-0.07 |
| Change (%) |
-0.49% |
| Day's Open |
14.14 |
| Day's Range |
14.00 - 14.29 |
| Day's Volume |
24,350 |
| 52-Week Range |
6.71 - 22.44 |
More Stats
| Market Cap |
246.54M |
| Enterprise Value |
248.01M |
| Earnings Date (est) |
Sep 3, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
17.36M |
| Float |
11.85M |
| EPS (basic) |
-0.73 |
| EPS (diluted) |
-0.88 |
| FCF / Share |
-1.37 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
602,702 |
| Short Ratio |
7.56 |
| Short % of Float |
5.59% |
| Beta |
1.20 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
4.21 |
| PB Ratio |
1.60 |
| Revenue |
58.52M |
| Operating Income |
-14.20M |
| Net Income |
-11.23M |
| Free Cash Flow |
-22.79M |
| Net Cash |
-1.48M |
| Net Cash / Share |
-0.09 |
| Gross Margin |
46.61% |
| Operating Margin |
-24.26% |
| Profit Margin |
-19.20% |
| FCF Margin |
-38.95% |
| ROA |
-5.81% |
| ROE |
-12.60% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$21.00*
(47.89% upside)
Low
18.0
Current: $14.20
High
23.0
Target: 21.00
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 38.85 | 36.68 | 27.27 | 23.11 | 22.20 | 17.06 | 14.83 | 15.68 | 12.37 | 13.37 |
| Revenue Growth | 5.91% | 34.51% | 17.98% | 4.09% | 30.15% | 15.06% | -5.43% | 26.71% | -7.47% | - |
| Gross Profit | 27.28 | 26.88 | 19.05 | 15.47 | 14.92 | 11.13 | 7.40 | 9.21 | 7.09 | 6.53 |
| Operating Income | -7.41 | -2.94 | -6.60 | -5.83 | -1.71 | -2.55 | -5.32 | -1.49 | -2.73 | -3.96 |
| Net Income | -7.39 | -7.61 | -1.68 | -1.17 | 5.57 | 1.39 | -2.67 | 0.37 | -3.53 | -2.86 |
| Shares Outstanding | 9.33 | 9.01 | 8.40 | 7.78 | 7.58 | 7.23 | 7.05 | 7.00 | 7.00 | 7.00 |
| Earnings Per Share | -0.79 | -0.87 | -0.22 | -0.17 | 0.69 | 0.19 | -0.38 | 0.05 | -0.50 | -0.41 |
| EPS Growth | - | - | - | - | 263.16% | - | - | - | - | - |
| Operating Cash Flow | -3.68 | -0.56 | -1.27 | -0.32 | 0.02 | 0.70 | -0.47 | -1.42 | -0.99 | -0.81 |
| Capital Expenditures | -0.68 | -0.38 | -0.49 | -0.47 | - | -0.07 | -0.53 | -0.47 | -0.64 | -1.05 |
| Free Cash Flow | -4.37 | -0.94 | -1.76 | -0.79 | 0.02 | 0.63 | -1.00 | -1.89 | -1.64 | -1.86 |
| Cash & Equivalents | 7.84 | 10.98 | 11.56 | 9.05 | 9.62 | 7.04 | 5.81 | 6.47 | 7.09 | 10.98 |
| Total Debt | - | - | - | - | - | - | - | - | - | 0.19 |
| Net Cash / Debt | 7.84 | 10.98 | 11.56 | 9.05 | 9.62 | 7.04 | 5.81 | 6.47 | 7.09 | 10.78 |
| Assets | 29.95 | 29.02 | 33.37 | 27.73 | 26.45 | 19.53 | 17.36 | 18.31 | 18.36 | 20.46 |
| Liabilities | 8.25 | 4.62 | 5.23 | 3.33 | 2.70 | 3.18 | 3.58 | 2.72 | 3.48 | 2.33 |
| Book Value | 21.70 | 24.40 | 28.14 | 24.40 | 23.75 | 16.35 | 13.78 | 15.59 | 14.88 | 18.13 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Misonix, Inc. |
| Country |
United States |
| Employees |
125 |
| CEO |
Stavros G. Vizirgianakis |
Stock Information
| Ticker Symbol |
MSON |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: MSON |
| IPO Date |
January 23, 1992 |
Description
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.